Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2026 · second_quarter · Q2
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2026 · first_quarter · Q1
Source: Senate LDA
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2025 · fourth_quarter · Q4
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2025 · third_quarter · Q3
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2025 · second_quarter · Q2
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2025 · first_quarter · Q1
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2024 · fourth_quarter · Q4
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2024 · third_quarter · Q3
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2024 · second_quarter · Q2
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2024 · first_quarter · Q1
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2023 · fourth_quarter · Q4
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2023 · third_quarter · 3A
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2023 · third_quarter · Q3
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2023 · second_quarter · Q2
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2023 · first_quarter · Q1
Monitor health and tax legislation as it relates to the biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2022 · fourth_quarter · Q4
Monitor health and tax legislation relating to biotechnology industry. Advocacy for bringing newly formed ARPA-Hs (Advanced Research Projects Agency for Health) headquarters to Massachusetts.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2022 · third_quarter · Q3
Monitor health and tax legislation relating to biotechnology industry. Advocacy for bringing newly formed ARPA-Hs (Advanced Research Projects Agency for Health) headquarters to Massachusetts.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2022 · second_quarter · Q2
Monitor health and tax legislation relating to biotechnology industry. Advocacy for bringing newly formed ARPA-Hs (Advanced Research Projects Agency for Health) headquarters to Massachusetts.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2022 · first_quarter · Q1
Monitor health and tax legislation relating to biotechnology industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2021 · fourth_quarter · Q4
Monitor health and tax legislation relating to biotechnology industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2021 · third_quarter · Q3
Monitor health and tax legislation relating to biotechnology industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2021 · second_quarter · Q2
Monitor health and tax legislation relating to biotechnology industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2021 · first_quarter · Q1
Monitor health and tax legislation relating to biotechnology industry
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2020 · fourth_quarter · Q4
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to fund National Institutes of Health for Fiscal Year 2022
Support legislation to support U.S. patent system
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2020 · third_quarter · Q3
Support legislation to support U.S. patent system
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Issues associated with proposed changes to the 340B Discount Drug Program
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2020 · second_quarter · Q2
Support legislation to support U.S. patent system
Issues associated with proposed changes to the 340B Discount Drug Program
Support legislation to fund National Institutes of Health for Fiscal Year 2021
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2020 · first_quarter · Q1
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to fund National Institutes of Health for Fiscal Year 2021
Support legislation to support U.S. patent system
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2019 · fourth_quarter · Q4
Issues associated with proposed changes to the 340B Discount Drug Program
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to support U.S. patent system
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2019 · third_quarter · Q3
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to fund National Institutes of Health for Fiscal Year 2020
Monitor health and tax legislation relating to biotechnology industry.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2019 · second_quarter · Q2
Support legislation to fund National Institutes of Health for Fiscal Year 2020
Monitor health and tax legislation relating to biotechnology industry.
Issues associated with proposed changes to the 340B Discount Drug Program
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2019 · first_quarter · Q1
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Issues associated with proposed changes to the 340B Discount Drug Program
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2018 · fourth_quarter · Q4
Support legislation to fund the National Institutes of Health for Fiscal Year 2019
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Monitor health anfd tax legislation pertaining to biotechnology industry.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2018 · third_quarter · Q3
Monitor health anfd tax legislation pertaining to biotechnology industry.
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Meetings regarding issues associated with the Patient Protection and Affordable Care Act and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2018 · second_quarter · Q2
Monitor health anfd tax legislation pertaining to biotechnology industry.
Support legislation to strengthen the U.S patent system
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2018 · first_quarter · Q1
Support legislation to strengthen the U.S patent system
Meetings regarding issues associated with the Patient Protection and Affordable Care Act and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to fund the National Institutes of Health for Fiscal Year 2019
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2017 · fourth_quarter · Q4
Meetings regarding issues associated with the Patient Protection and Affordable Care Act and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to strengthen the U.S patent system
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2017 · third_quarter · Q3
Meetings regarding issues associated with the Patient Protection and Affordable Care Act and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to fund the National Institutes of Health for Fiscal Year 2018
Monitor health anfd tax legislation pertaining to biotechnology industry.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2017 · second_quarter · Q2
Support legislation to strengthen the U.S patent system
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Monitor health anfd tax legislation pertaining to biotechnology industry.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2017 · first_quarter · Q1
Monitor health anfd tax legislation pertaining to biotechnology industry.
Support legislation to strengthen the U.S patent system
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2016 · fourth_quarter · Q4
Support legislation to strengthen the U.S. Patent System
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Meetings regarding issues associated with the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2016 · third_quarter · Q3
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to fund the National Institutes of Health for Fiscal Year 2017
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2016 · second_quarter · Q2
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to strengthen the U.S. Patent System
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2016 · first_quarter · Q1
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to strengthen the U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2015 · fourth_quarter · Q4
Support legislation to fund the National Institutes of Health for Fiscal Year 2016
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2015 · third_quarter · Q3
Support legislation to strengthen the U.S. Patent System
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2015 · second_quarter · Q2
Support legislation to strengthen the U.S. Patent System
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2015 · first_quarter · Q1
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to strengthen the U.S. Patent System
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2014 · fourth_quarter · Q4
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment Advisory Board and use of comparative effectiveness research.
Support legislation to fund the National Institutes of Health for Fiscal Year 2015
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2014 · second_quarter · 2A
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to strengthen the U.S Patent System
Support legislation to fund the National Institutes of Health
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2014 · third_quarter · Q3
Support legislation to strengthen U.S. Patent System
Support legislation to fund the National Institutes of Health for Fiscal Year 2015
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment Advisory Board and use of comparative effectiveness research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2014 · second_quarter · Q2
Support legislation to fund the National Institutes of Health for Fiscal Year 2015
Support legislation to strengthen the U.S. Patent System.
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2014 · first_quarter · Q1
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to fully fund the National Institutes of Health for Fiscal Year 2015
Support legislation to strengthen the U.S. Patent System
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2013 · fourth_quarter · Q4
Support legislation to strengthen U.S. Patent System
Support legislation related to reauthorization of SBIR/STRR
Support legislation to fund the National Institutes of Health
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2013 · third_quarter · Q3
Support legislation related to reauthorization of SBIR/STRR
legislation related to biosimilars
Support legislation to fund the National Institutes of Health
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2013 · second_quarter · Q2
Support legislation to strengthen U.S. Patent System
Legislation related to biosimilars
Support legilsation to fund the National Institutes of Health
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2013 · first_quarter · Q1
Support legislation to strengthen U.S patent system
Legislation related to biosimilars
Support legislation related to reauthorization of SBIR/STTR
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2012 · fourth_quarter · Q4
Support legislation related to reauthorization of SBIR/STTR
Support legislation to fund the National Institutes of Health
Legislation related to biosimilars
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2012 · third_quarter · Q3
Legislation related to biosimilars
Support legislation to strengthen U.S. patent system
Support legislation related to reauthorization of SBIR/STTR
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2012 · second_quarter · Q2
Support legislation related to reauthorization of SBIR/STTR
Legislation related to biosimilars
Support legislation to fund National Institutes of Health
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2012 · first_quarter · Q1
Support legislation to strengthen U.S. patent system
Support legislation to fund National Institutes of Health
Support legislation related to reauthorization of SBIR/STTR
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2011 · fourth_quarter · Q4
Legislation related to biosimilars
Support Funding for National Institutes of Health
Support legislation to strengthen U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2011 · third_quarter · Q3
Support Funding for National Institutes of Health
Legislation related to biosimilars
Support legislation to stregthen U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2011 · second_quarter · Q2
Support Funding for National Institutes of Health
Support legislation to strengthen U.S. Patent System
Legislation related to biosimilars
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2011 · first_quarter · Q1
Support legislation related to Small Business Research Programming Grants
Support Funding for National Institutes of Health
Legislation related to biosimilars
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2010 · fourth_quarter · Q4
Support Funding for National Institutes of Health
Support legislation to fund Small Business Research Programming Grants
Support legislation to strengthen U.S Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2010 · third_quarter · Q3
Support legislation for Small Business Programming Grants
Support legislation to strengthen U.S. Patent System
Legislation related to biosimilars
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2010 · second_quarter · Q2
Support legislation to fund Small Business Programming Grants
Legislation related to biosimilars
Support legislation to strengthen U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2010 · first_quarter · Q1
Support funding for National Institutes of Health
Support legislation to strengthen U.S. Patent System
Legislation related to biosimilars
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2009 · fourth_quarter · Q4
Support legislation to fund Small Business Research Programming Grants
Legislation related to biosimilars
Support legislation to strengthen U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2009 · third_quarter · Q3
Legislation related to biosimilars
Support funding for National Institutes of Health
Support legislation to fund Small Business Research Programming Grants
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2009 · second_quarter · Q2
Support legislation to fund Small Business Research Program Grants
Support funding for National Institutes of Health
Support legislation to stregnthen U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2009 · first_quarter · Q1
Support legislation to fund Small Business Research Program Grants
Support Funding for National Institutes of Health
Support legislation to strengthen U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2008 · fourth_quarter · Q4
Support Funding for the National Institutes of Health
Support legislation to fund Small Business Research Program Grants
Support legislation to stregthen U.S. Patent System
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2008 · third_quarter · Q3
Support legislation to fund Small Business Research Program Grants
Support for funding for the National Institutes of Health
Legislation related to biosimilars
MASSACHUSETTS BIOTECHNOLOGY COUNCIL via MASSACHUSETTS BIOTECHNOLOGY COUNCIL
2008 · second_quarter · Q2
Support legislative initiatives to strengthen U.S. Patent System
Support for funding for the National Institutes of Health
Support legislation to fund Small Business Research Program Grants
Issues associated with proposed changes to the 340B Discount Drug Program
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Support legislation to fund National Institutes of Health for Fiscal Year 2021
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Monitor health and tax legislation relating to biotechnology industry.
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Issues associated with proposed changes to the 340B Discount Drug Program
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Monitor health and tax legislation relating to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Monitor health and tax legislation relating to biotechnology industry.
Support legislation to fund National Institutes of Health for Fiscal Year 2020
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Issues associated with proposed changes to the 340B Discount Drug Program
Support legislation to support U.S. patent system
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Issues associated with legislative and administrative proposals regarding the pricing of biopharmaceuticals, including biosimilars
Support legislation to support U.S. patent system
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund National Institutes of Health for Fiscal Year 2020
Monitor health and tax legislation relating to biotechnology industry.
Support legislation to support U.S. patent system
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Meetings regarding issues associated with the Patient Protection and Affordable Care Act and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to strengthen the U.S patent system
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2019
Support legislation to strengthen the U.S patent system
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Meetings regarding issues associated with the Patient Protection and Affordable Care Act and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to fund the National Institutes of Health for Fiscal Year 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Monitor health anfd tax legislation pertaining to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2019
Monitor health anfd tax legislation pertaining to biotechnology industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Meetings regarding proposed changes to Medicare Part B and Medicare Part D reimbursement that negatively impact patient access to innovative therapies.
Support legislation to strengthen the U.S patent system
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Meetings regarding issues associated with the Patient Protection and Affordable Care Act and alternative legislation's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Support legislation to fund the National Institutes of Health for Fiscal Year 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2018
Meetings regarding issues associated with the Patient Protection and Affordable Care Act's impact on the biotechnology industry, including issues related to biosimilars, the Independent Payment and Advisory Board and use of comparative effectiveness research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2018
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen the U.S. Patent System
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen the U.S. Patent System
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund the National Institutes of Health for Fiscal Year 2015
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen the U.S. Patent System
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Meetings regarding issues associated with the implementation of the Patient Protection and Affordable Care Act impacting the biotechnology industry, including issues related to biosimilars, the Independent Payment Advisory Board and use of comparative effectiveness research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
Legislation related to biosimilars
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to stregthen U.S. Patent System
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation related to reauthorization of SBIR/STRR
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Implementation of Patient Protection and Affordable Care Act
Support legislation to fund National Institutes of Health
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen U.S. patent system
Patient Protection and Affordable Care Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund National Institutes of Health
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen U.S. patent system.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Legislation related to biosimilars
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation related to reauthorization of SBIR/STTR
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation related to reauthorization of SBIR/STTR
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation related to Small Business Research and Programming Grants
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen U.S. Patent System
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Legislation related to biosimilars
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support Funding for National Institutes of Health
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support funding for National Institutes of Health
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to fund Small Business Research Programming Grants
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support funding for National Institutes of Health
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen U.S. Patent System
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Legislation related to biosimilars
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Legislation related to biosimilars
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Legislation related to biosimilars
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Support legislation to strengthen U.S. Patent System
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE
Legislation related to biosimilars
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Patent & Trademark Office (PTO), SENATE